Aflunov

Aflunov is a vaccine designed to protect against the H5N1 influenza strain. It is administered intramuscularly and is manufactured by Seqirus S.R.L. in the EU. This vaccine is intended for use in preventing influenza caused by the H5N1 virus.

Aflunov is used to provide immunity against the H5N1 influenza strain, commonly known as avian flu. It is typically administered to individuals who are at risk of exposure to this particular strain of the virus. The vaccine works by stimulating the body's immune response to develop antibodies against the H5N1 virus, thereby offering protection against infection.

Common effects of Aflunov may include mild soreness or redness at the injection site. Some individuals might experience temporary flu-like symptoms such as fever, fatigue, or muscle aches. These effects are generally mild and short-lived, indicating that the body is building immunity against the H5N1 virus.

Aflunov should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to vaccines or any of the components in Aflunov should consult their healthcare provider before receiving the vaccine. It is important to inform the healthcare provider about any current medications or health conditions.

Aflunov may interact with certain medications or health conditions. It is advisable to discuss any current medications, including over-the-counter drugs and supplements, with a healthcare provider before receiving the vaccine. Additionally, individuals with weakened immune systems or those undergoing immunosuppressive therapy should consult their healthcare provider.